iasc wclc 2021: cx-2029 and amg 757 for lung cancer
Published 3 years ago • 168 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
1:31
wclc 2021 highlights
-
1:00:37
wclc 2021 highlights
-
2:47
update from a phase 1 study of amg 757 in sclc
-
5:52
highlights from wclc 2021
-
31:11
iaslc-wclc 2021 clinical panel
-
2:50
immunotherapy updates from wclc 2021
-
3:19
cap iaslc amp guideline overview
-
1:38
moving forward: targeted therapies in early-stage lung cancer
-
5:38
amg 757: dll3 targeting, half-life extended bispecific t-cell engager immuno-oncology therapy, i...
-
2:21
a phase 1 study of amg 757
-
4:08
targeted therapies in lung cancer
-
51:17
different tests different drivers: the power of collaboration to solve a molecular mystery
-
4:10
case 3: extensive-stage sclc
-
1:05
how is small cell lung cancer (sclc) diagnosed?
-
2:44
lca-ne advocate john atkinson
-
2:37
outcomes of patients with sclc following surgical resection
-
0:53
iaslc wclc testimonial - erin sarauer